TITLE

Sarcoidosis Presenting as Massive Splenic Infarction

AUTHOR(S)
Patel, Ishita; Ismajli, Mediola; Steuer, Alan
PUB. DATE
January 2012
SOURCE
Case Reports in Rheumatology;2012, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Sarcoidosis is a multisystem granulomatous disease of unknown aetiology. Granulomatous inflammation involving the spleen is common and associated with splenomegaly. However, massive splenomegaly is a rare occurrence. Infrequently massive splenomegaly can result in splenic infarction. Massive splenic infarction in sarcoidosis has, to our knowledge, not been previously reported. We present a case of a woman presenting with massive splenic infarction and sarcoidosis confirmed by granulomatous inflammation of the liver.
ACCESSION #
86827686

 

Related Articles

  • ASPECTE ECOGRAFICE ALE VASELOR SPLINEI ÃŽN DINAMICA VÂRSTEI. ACHIM, O. F.; VEŞTEMEAN, IOANA LUCIA // Acta Medica Transilvanica;dec2012, Vol. 17 Issue 4, p73 

    Measuring spleen vessels velocities involves a high degree of difficulty in children because of the poor cooperation often encountered in current practice and of the small size caliber of these vessels. The study aims at measuring the velocities on the splenic artery, portal vein and splenic...

  • Comparative treatment and literature review for laparoscopic splenectomy alone versus preoperative splenic artery embolization splenectomy. Wu, Zhong; Zhou, Jin; Pankaj, Prasoon; Peng, Bing // Surgical Endoscopy;Oct2012, Vol. 26 Issue 10, p2758 

    Background: Although laparoscopic splenectomy has been gradually regarded as an acceptable therapeutic approach for patients with massive splenomegaly, intraoperative blood loss remains an important complication. In an effort to evaluate the most effective and safe treatment of splenomegaly, we...

  • The treatment of inflammatory bowel disease in children. Wyllie, Robert; Sarigol, Samra // Clinical Pediatrics;Jul1998, Vol. 37 Issue 7, p421 

    Editorial. Discusses the treatment of inflammatory bowel disease in children. Symptoms of inflammatory bowel disease; Efficacy of metronidazole; Study on corticosteroid analogues; Nutritional intervention in Crohn's disease.

  • Inflammatory bowel disease. Galper, Charlotte; Cerda, James; Hanauer, Stephen B.; Peppercorn, Mark A.; Wexner, Steven D. // Patient Care;3/15/1998, Vol. 32 Issue 5, p81 

    Focuses on treatments for inflammatory bowel diseases (IBDs). Detailed information on ulcerative colitis (UC), crohn's disease (UC) and their treatments; Reference to nutritional therapy; Precautions with the use of corticosterioids for IBD patients; Indepth look at several therapies for IBD. ...

  • The epidemiology of inflammatory bowel diseases in Finland.  // Inflammatory Bowel Disease Monitor;2011, Vol. 11 Issue 3, p121 

    The article discusses the prevalence and control of inflammatory bowel disease (IBD) like ulcerative colitis (UC) and Crohn's disease in Tampere, Finland from 1986-1999.

  • Research yields to technology in the fight against IBD. Williams, Craig // Drug Topics;9/20/93, Vol. 137 Issue 18, p36 

    Reports on the advances made by technology in the treatment of inflammatory bowel disease (IBD). Pentasa drug as a new formulation of 5-ASA (mesalamine); Drug designed to bypass the stomach for intestinal delivery; Educational library and on-line communications with physicians who treat IBD...

  • Management of inflammatory bowel disease. Botoman, V. Alin; Bonner, Gregory F.; Botoman, Daniela A. // American Family Physician;1/1/1998, Vol. 57 Issue 1, p57 

    Presents information on inflammatory bowel disease while focusing the management of ulcerative colitis and Crohn's disease in the United States. Percentage of the U.S population which this disease affects; Information on ulcerative colitis; Detailed information on Crohn's disease; Indepth look...

  • Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population based case-control study.  // International Journal of Advances in Rheumatology;2010, Vol. 8 Issue 4, p150 

    The article presents a case-control study that investigates the effectiveness of azathioprine in treating inflammatory bowel disease in Great Britain.

  • Pharmacologic therapy for inflammatory bowel disease. Hirschfeld, Sondra; Clearfield, Harris R. // American Family Physician;6/1/1995, Vol. 51 Issue 8, p1971 

    Discusses the pharmacologic management of inflammatory bowel diseases, ulcerative colitis and Crohn's disease. Use of sulfasalazine; Development of 5-aminosalicylic acid (5-ASA); Topical therapy; Corticosteroid therapy; Antibiotic therapy; Immunosuppressive therapy.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics